Cargando…
Methylphenidate remediates aberrant brain network dynamics in children with attention-deficit/hyperactivity disorder: A randomized controlled trial
Methylphenidate is a widely used first-line treatment for attention deficit/hyperactivity disorder (ADHD), but the underlying circuit mechanisms are poorly understood. Here we investigate whether a single dose of osmotic release oral system methylphenidate can remediate attention deficits and aberra...
Autores principales: | Mizuno, Yoshifumi, Cai, Weidong, Supekar, Kaustubh, Makita, Kai, Takiguchi, Shinichiro, Tomoda, Akemi, Menon, Vinod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286726/ https://www.ncbi.nlm.nih.gov/pubmed/35640787 http://dx.doi.org/10.1016/j.neuroimage.2022.119332 |
Ejemplares similares
-
Bayesian dynamical system analysis of the effects of methylphenidate in children with attention-deficit/hyperactivity disorder: a randomized trial
por: Cai, Weidong, et al.
Publicado: (2023) -
Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
por: Fujioka, Toru, et al.
Publicado: (2016) -
Structural brain abnormalities in children and adolescents with comorbid autism spectrum disorder and attention-deficit/hyperactivity disorder
por: Mizuno, Yoshifumi, et al.
Publicado: (2019) -
Neural and behavioral effects of parent training on emotion recognition in mothers rearing children with attention-deficit/hyperactivity disorder
por: Makita, Kai, et al.
Publicado: (2023) -
Catechol-O-methyltransferase polymorphism is associated with the cortico-cerebellar functional connectivity of executive function in children with attention-deficit/hyperactivity disorder
por: Mizuno, Yoshifumi, et al.
Publicado: (2017)